Antigen-Specific T-Cell Activation Independently of the MHC: Chimeric Antigen Receptor-Redirected T Cells
about
Beyond CD19: Opportunities for Future Development of Targeted Immunotherapy in Pediatric Relapsed-Refractory Acute LeukemiaBispecific T-cell engagers for cancer immunotherapy.Overcoming tumor immune evasion with an unique arbovirusIdentification of patient-specific and tumor-shared T cell receptor sequences in renal cell carcinoma patientsThe role of tumor/dendritic cell interactions in the regulation of anti-tumor immunity: the good, the bad, and the uglyIn Vivo Murine-Matured Human CD3+ Cells as a Preclinical Model for T Cell-Based Immunotherapies.Synthetic biology for therapeutic applications.Characteristics of Tumor Infiltrating Lymphocyte and Circulating Lymphocyte Repertoires in Pancreatic Cancer by the Sequencing of T Cell Receptors.Cellular and molecular immunology of lung cancer: therapeutic implications.Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein.A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumors.Chimeric Antigen Receptor T-Cell Therapy for the Community OncologistImmunological quality and performance of tumor vessel-targeting CAR-T cells prepared by mRNA-EP for clinical research.The expanding horizon of immunotherapy in the treatment of malignant disorders: allogeneic hematopoietic stem cell transplantation and beyond.Adoptive therapy with CAR redirected T cells: the challenges in targeting solid tumors.Enhancement of antitumor activity by using a fully human gene encoding a single-chain fragmented antibody specific for carcinoembryonic antigen.Chimeric antigen receptor modified T cells that target chemokine receptor CCR4 as a therapeutic modality for T-cell malignancies.Spotlight on chimeric antigen receptor engineered T cell research and clinical trials in China.Chimeric antigen receptors for treatment of glioblastoma: a practical review of challenges and ways to overcome them.Immune and viral therapies for malignant primary brain tumors.Prevention of Allograft Rejection by Use of Regulatory T Cells With an MHC-Specific Chimeric Antigen Receptor.Chimeric Antigen Receptor-Redirected Regulatory T Cells Suppress Experimental Allergic Airway Inflammation, a Model of AsthmaReprogramming T-cells for adoptive immunotherapy of ovarian cancer.Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications.Adoptive transfer of murine T cells expressing a chimeric-PD1-Dap10 receptor as an immunotherapy for lymphoma.TCR engagement negatively affects CD8 but not CD4 CAR T cell expansion and leukemic clearance.Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy.Avoidance of On-Target Off-Tumor Activation Using a Co-stimulation-Only Chimeric Antigen Receptor.Enhancing cancer immunotherapy through nanotechnology-mediated tumor infiltration and activation of immune cells.Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations.The application of CAR-T cell therapy in hematological malignancies: advantages and challengesThe potential of CAR T therapy for relapsed or refractory pediatric and young adult B-cell ALLEarly Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis
P2860
Q26781328-4D283CD4-C750-48AF-9215-B9A4A126F5B6Q27693313-01A4D5BD-3290-4FB7-94D2-5F4F07F65952Q28081774-E640C1BF-42D4-4214-88EE-D7F6040B39C0Q30313444-19CFBC3C-0F90-415E-8BF9-2B697672D6D4Q30413213-F8F7CE30-B82C-4E10-A32B-7E438B2D54D6Q33796950-0A817DA2-1FED-40E3-BABB-C126C28209BDQ35057524-2A22A3E0-1D7F-46F9-BB3F-6D1C22C5C0BFQ36017958-3FC06B7E-74BD-4B99-930F-9AA2428278C4Q36130505-E68FFC02-89A9-43CE-9ED8-25E59BD7D07FQ36682313-5FA66071-CB2D-4756-BED9-58D784FCA117Q36709308-AD6570E5-D669-4DE9-B90E-7F51C8EEA45BQ36884399-666284E0-F423-40FD-B5EF-40CCD387ED92Q37417622-49CDA2DC-5EB9-42A4-9952-14091C4CEE4FQ38216836-65706177-AE7B-4840-9D02-D95AFD3C3F29Q38525034-C99138A0-7A96-45D6-AC6C-A2E4C89F0E31Q38693634-3C6C8E2A-CC8A-4D65-B90B-F737E8EF822AQ38702312-DA9B3687-ECA5-4290-B753-FD21C71EF8F3Q38786626-1F5631B9-DAF4-41AA-81EF-55484F135C23Q38987239-43628A2F-0C1F-4D92-952A-5DC6E9DE2130Q39168899-547BC378-76E0-42BF-A8CF-92983F7453A0Q40402774-C81B5A60-AA24-4391-A27E-3653BAE93E1AQ41684124-E3064DC7-EB8D-4EA3-AFB0-F593551617EBQ47201278-79AE2905-0FFB-42E5-AC5A-A4A54D7399EBQ47561397-2BA1F4DE-6A1C-4266-84C6-194F4D58D425Q48188242-BBFE55C9-0C3C-4124-8A56-2952DBF4E318Q48250863-FD5B6EF4-AE6F-48B7-8D4C-5C40A4826011Q49432766-C91E89FD-9044-4062-9193-687AE8AAD9E9Q50034000-59F67B99-9D5B-42D4-A57E-4398167F3662Q50426810-9FDE2B47-DCAA-44EC-89E6-143766FF5E83Q54963955-DF56DB67-E4EB-4304-888F-23E67D2B1B4CQ57177485-F1A8EE8D-7A70-4B24-BC8D-6CEBFCE0598DQ58767159-FC442CA2-216A-4C90-9115-E22921F4E700Q58788761-9C39FD27-3E53-4D73-8D6D-C8144DBBAF78
P2860
Antigen-Specific T-Cell Activation Independently of the MHC: Chimeric Antigen Receptor-Redirected T Cells
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Antigen-Specific T-Cell Activa ...... en Receptor-Redirected T Cells
@ast
Antigen-Specific T-Cell Activa ...... en Receptor-Redirected T Cells
@en
Antigen-Specific T-Cell Activa ...... en Receptor-Redirected T Cells
@nl
type
label
Antigen-Specific T-Cell Activa ...... en Receptor-Redirected T Cells
@ast
Antigen-Specific T-Cell Activa ...... en Receptor-Redirected T Cells
@en
Antigen-Specific T-Cell Activa ...... en Receptor-Redirected T Cells
@nl
prefLabel
Antigen-Specific T-Cell Activa ...... en Receptor-Redirected T Cells
@ast
Antigen-Specific T-Cell Activa ...... en Receptor-Redirected T Cells
@en
Antigen-Specific T-Cell Activa ...... en Receptor-Redirected T Cells
@nl
P2093
P2860
P356
P1476
Antigen-Specific T-Cell Activa ...... en Receptor-Redirected T Cells
@en
P2093
Andreas A. Hombach
Hinrich Abken
Markus Chmielewski
P2860
P356
10.3389/FIMMU.2013.00371
P407
P577
2013-01-01T00:00:00Z